glp 1 receptor agonist weight loss Balancing and muscle in GLP1 therapy Anti-obesity drugs are closing the
Description
In the U.S., GLP-1 prescriptions more than doubled in just 18 months, topping nine million by early 2024

GLP-1 medications work by mimicking the effects of this hormone, leading to various beneficial outcomes for individuals with Type 2 diabetes and those struggling with obesity
[DOI] [PubMed] [Google Scholar] 122.Balantekin K.N., Kretz M.J., Mietlicki-Baase E.G
Zepbound is FDA-approved both for chronic weight management and for moderate-to-severe obstructive sleep apnea in adults with obesity the OSA indication creates a second documented medical-necessity path when an OSA diagnosis is on file
